Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/1996
08/29/1996WO1996025953A1 Redirection of cellular immunity by receptor chimeras
08/29/1996WO1996025947A2 Induction of e-selectin for targetting therapeutic agents
08/29/1996WO1996025941A1 Modulators of regulatory proteins
08/29/1996WO1996019580A3 Telomerase protein component
08/29/1996WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR
08/29/1996WO1996009391A3 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
08/29/1996CA2213610A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996CA2213484A1 Modulators of regulatory proteins
08/29/1996CA2213469A1 Novel osteoclastogenesis inhibitory factor and methods for producing same
08/29/1996CA2213428A1 A method for the isolation and purification of lipid cell-wall components
08/29/1996CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996CA2212846A1 Prostate-specific membrane antigen and uses thereof
08/28/1996EP0728215A1 METHOD OF BINDING MATERIAL TO THE $g(b)-AMYLOID PEPTIDE
08/28/1996EP0728203A1 Analogous peptides of the internal image of a viral protein
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728142A1 Novel antler-derived bone growth factors
08/28/1996EP0728023A1 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells
08/28/1996EP0728017A1 Treatment of bacterially-induced inflammatory diseases
08/28/1996EP0728016A1 Use of anti-idiotypic antibodies to prevent hyperacute rejection of xenografts
08/28/1996EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes
08/28/1996EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family
08/28/1996EP0406297B1 Medical use of neuropeptide Antagonist G
08/28/1996CN1129984A Immunoassay for soluble fibrin polymers
08/28/1996CN1129958A Method of identifying human and animal cells capable of unlimited proliferation or tumour formation
08/27/1996US5550223 Lipoprotein I (ompi) of pseudomonas aeruginosa
08/27/1996US5550221 Genetic engineering
08/27/1996US5550108 Adding an 18 kda c5b-9 inhibitory protein to prevent platelet and endothelial cell activation
08/27/1996US5550055 Recombinant DNA-produced T11 and fragments thereof
08/27/1996US5550052 Useful for detection of lav antibodies in human sera
08/27/1996US5550049 Useful as insecticides and arachnicidic agents
08/27/1996US5550045 Efficient production of enzyme useful for degrading pectin
08/27/1996US5550043 Expression of heterologous proteins in Drosophila cells
08/27/1996US5550027 Screening blood donors for chagas disease
08/27/1996US5550026 Antibodies to human gastrin-releasing peptide precursor and use thereof
08/27/1996US5550023 Amplification of human MDM2 gene in human tumors
08/27/1996US5550022 A nucleic acid molecule, atleast 27 nucleotides in length,specific for strains of listeria bacteria, hybridizes with specific nucleotide sequence or complementary sequence
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5550017 Anti-paramyxovirus screening method and vaccine
08/27/1996US5549898 Parasiticides
08/27/1996US5549896 For prophylaxis, diagnosis
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
08/27/1996US5549882 Imaging infectious foci with human IgM 16.88
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025497A1 New chemokines expressed in pancreas
08/22/1996WO1996025495A1 Sperm factor
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025436A1 Recombinant human anti-lewis b antibodies
08/22/1996WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE
08/22/1996WO1996025433A1 B cell differentiation and proliferation factors and methods for obtaining and using the same
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025175A1 ADMINISTRATION OF A CYCLOSPORINE-SPECIFIC MONOCLONAL ANTIBODY THAT CROSS-REACTS WITH HIV-1 p24 GAG TO TREAT HIV INFECTION
08/22/1996WO1996025174A1 Muscle protein decomposition inhibitor containing il-6 receptor antibody
08/22/1996WO1996025155A1 Diagnosis of and compositions and methods for the treatment of disease
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/21/1996EP0727489A1 DNA sequence coding for an A. thaliana protein with delta-5,7-sterol-delta-7-reductase, the protein, process for the production, transformed yeast-strains and use
08/21/1996EP0727486A2 Tumour suppressor gene
08/21/1996EP0727438A2 Adducts of PEG and GM-CSF
08/21/1996EP0727437A2 Covalent PEG-protein adducts
08/21/1996EP0727436A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727435A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727226A2 Process for removing viruses from protein solutions by ultrafiltration
08/21/1996EP0726961A1 Diagnosis of mental disorders
08/21/1996EP0726959A1 Identification of dna-damaging substances by means of cell lines capable of overexpressing poly(adp-ribose)-polymerase
08/21/1996EP0726957A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726949A1 Opioid receptor: compositions and methods
08/21/1996EP0726942A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
08/21/1996EP0726915A1 A ligand capable of binding to the adenosine deaminase binding-site of cd26
08/21/1996EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use
08/21/1996EP0726913A1 Cytokines from natural killer or t cells
08/21/1996EP0726912A1 Cd6 ligand
08/21/1996EP0726910A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726770A1 Sulfamethoxazole-specific immunosuppressive agents
08/21/1996EP0593440B1 Use of honey as vaccine
08/21/1996CN1129460A Epstein-barr virus dna sequences encoding diagnostically relevant virus capid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic
08/20/1996US5548066 Failure of passive transfer immune serum and method of making same
08/20/1996US5548065 Stimulating proliferation and/or differentiation of primitive mammalian hematopoietic stem cells
08/20/1996US5547940 Using a polypeptide
08/20/1996US5547933 Production of erythropoietin
08/20/1996US5547932 Transfection
08/20/1996US5547928 Detection of a protein in tissue and body fkuid sample
08/20/1996US5547855 Kainate-binding human CNS glutamate receptors EAA3C and EAA3D, DNA encoding them, and expression of the DNA in transformed cells
08/20/1996US5547854 DNA encoding a receptor for Mullerian inhibitory substance, misr1, and corresponding vectors, cells, probes, and recombinant methods
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547846 Immunogenic regions on the E7 protein of human papillomavirus type 16
08/20/1996US5547839 Contacting polynucleotides with surface of solid substrate, hybridizing using nucleic acid polymerase and labeled nucleotide
08/20/1996US5547834 Recombinant CMV neutralizing proteins
08/20/1996US5547669 Isolated peptide comprising regions having human t-cell stimulating activity, each comprising t-cell epitope of protein allergen arranged in configuration different from that occuring naturally
08/20/1996US5547668 Conjugates of folate anti-effector cell antibodies